TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
about
Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host DiseasesThe role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantationPossible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationDanger Signals and Graft-versus-host Disease: Current Understanding and Future PerspectivesSeparating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.TLR signals promote IL-6/IL-17-dependent transplant rejection.Thyroid antigens, not central tolerance, control responses to immunization in BALB/c versus C57BL/6 mice.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseBlood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationEffective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.HDAC inhibition and graft versus host diseaseVarious forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHDInnate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantationTargeting deacetylases to improve outcomes after allogeneic bone marrow transplantation.Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host diseaseHighlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.The biology of allogeneic hematopoietic cell resistanceNew perspectives on the biology of acute GVHD.Immunoregulation of GVHD by triggering the innate immune system with CpG.Danger signals activating innate immunity in graft-versus-host disease.Role of gut microbiota in graft-versus-host disease.GVHD prevention: an ounce is better than a pound.Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement.Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.The role of bacteria and pattern recognition receptors in GVHDExpansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning.Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
P2860
Q26741220-A11DBA85-0CC3-44D1-B5F7-C652CC3ECAC3Q26824436-74579D61-12D9-483E-9437-489E6D9EE1CEQ27001015-19B13376-E69C-41A2-ABCA-2D4ED9027EBFQ28075204-AD0A27F3-ADE0-44FB-ADE7-B7DBB1C17172Q33685495-F986FBD4-E892-4DB4-8669-057FEAAE9645Q33711191-675A4C21-E46B-495A-81F7-2A187E0CD7B1Q33801392-02F13808-F7E2-4B97-82A4-F22394FE7A6AQ33835099-727C3AD3-A0BA-418C-998A-8C442258A6F8Q34618829-FA826466-6394-4B10-904A-9E34975FB595Q34755262-46DF258F-7B6A-437B-9DEA-7F7ED1FC8B69Q35016985-B9825FCD-EFE4-4237-8C01-80A52A8EE2B2Q35022269-CC3A7825-635B-4A23-9EB8-2DAADB3B8DCCQ35084400-FD8B44CD-E172-48B0-A5F8-EE73D5FD3B11Q35179622-724409A4-9D02-4FFD-ADED-904A385BDC37Q36091313-A729873F-6DA3-4E0B-8E1E-52D5493199BAQ36305350-9F7EB854-5201-4FF5-86A3-5E7BD0E5E217Q37026059-288A4899-C09F-497B-A326-338DB1E748B3Q37106785-1C4A381D-7884-4102-B3DF-2A05EC70EDB6Q37271276-A9E9CD2B-DE56-4680-88E7-00EA852CD450Q37452305-0E143BF2-1493-4AD5-8CE0-6B5774DF9B37Q37460355-E14C24E6-8ABD-4EED-AEF4-19DE8227AB93Q37603497-AA330FEB-9B8D-43EF-903A-B18A004DABEDQ37632886-F46B1F88-8A3E-442B-8F18-E28B2370A85EQ37641063-2E88F91C-6A44-4E50-A5A1-4328FFE30423Q37810081-CE10C7EB-FB9D-4EFE-8A4A-E8991A0DB467Q37875779-05B1A738-534F-4257-8C1C-CE381A4E91FBQ37887810-525225D8-5C48-4D73-A8E0-E7E7F642771BQ37973859-FAA68D3C-BA37-456C-B338-14FA8254D668Q38132090-6D4CFF6B-3772-44FF-8775-E41E4B2681DBQ38766473-71636356-AE21-403E-BE2B-19DF3A2C93E7Q40350452-3BD739AF-BB21-4FFC-8EED-8DDBB6B5CA2CQ41218452-1B6E6C78-D512-42F3-BE8C-28C7BD07520DQ45890363-BA3462E7-ED6B-4A5F-A6BC-7E36D40786E0Q50332623-EE20CBAF-DFA8-4AF1-B0D2-448024F47EAFQ53192236-2F230F2B-12BE-4D9F-A287-BC2B4DDA25F4Q59130037-761032E1-E94B-4958-AFF0-CDCC6E91B2D0
P2860
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
TLR agonists regulate alloresp ...... ogeneic bone marrow rejection.
@en
type
label
TLR agonists regulate alloresp ...... ogeneic bone marrow rejection.
@en
prefLabel
TLR agonists regulate alloresp ...... ogeneic bone marrow rejection.
@en
P2093
P2860
P1433
P1476
TLR agonists regulate alloresp ...... ogeneic bone marrow rejection.
@en
P2093
Arlene H Sharpe
Arthur M Krieg
Christopher J Lees
Hiroaki Hemmi
Michael J Ehrhardt
Patricia A Taylor
Robert B Levy
Shizuo Akira
William J Murphy
P2860
P304
P356
10.1182/BLOOD-2007-09-113670
P407
P577
2008-07-09T00:00:00Z